Table 1 Network meta-analysis of blood cell levels in COVID-19 patients with different clinical stages MD (95%CI)
Comparisons | WBC (× 109/L) | LYM (×109/L) | NEUT (×109/L) | MONO (×109/L) | PLT (×109/L) | HB (g/L) |
|---|---|---|---|---|---|---|
Severe VS. Mild a | 1.10 (0.68, 1.53) | −0.37 (− 0.44, − 0.31) | 1.20 (0.65, 1.75) | −0.03 (− 0.08, 0.01) | −18.87 (− 27.86, − 9.88) | −3.81 (− 5.43, − 2.19) |
Critical VS. Mild a | 2.26 (1.57, 2.95) | −0.58 (− 0.68, − 0.48) | 2.76 (1.92, 3.60) | −0.04 (− 0.10, 0.02) | −30.13 (− 45.24, − 15.03) | −3.99 (− 8.75, 0.76) |
Critical VS. Severe a | 1.16 (0.46, 1.86) | −0.21 (− 0.31, − 0.10) | 1.56 (0.70, 2.42) | −0.01 (− 0.08, 0.06) | −11.26 (− 26.74, 4.21) | −0.18 (− 5.04, 4.67) |
Inconsistency P-value | 0.070 | 0.150 | 0.115 | 0.871 | 0.793 | 0.484 |